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A previously healthy 35-year-old man fell from a height of 25 meters while pruning a tree. His fall was somewhat slowed by the untrimmed tree branches. The ground impact focused on the right thorax and axilla, with resultant closed head injury, right clavicular fracture, and multiple right-sided rib fractures with pneumo-and hemothorax. Emergent tube thoracotomy, tracheotomy, and orthopedic interventions were conducted. The patient's 10-day hospital course was notable for steady improvement, and, other than for a mild traumatic brain injury, he felt well on discharge. Prior to discharge, a loud holosystolic murmur, consistent with mitral regurgitation, was auscultated. The patient remained afebrile and there was no evidence of heart failure or systemic embolic phenomena. A transthoracic echocardiogram done during the admission was suggestive of severe mitral regurgitation, but images were technically suboptimal. The patient was eventually referred to our facility for transesophageal imaging and a consultation for the question of mitral valve repair. At the time of our evaluation, 6 months after the accident, he reported no cardiopulmonary symptoms and was able to hike 5 to 7 miles without dyspnea or fatigue. A screening transthoracic echocardiogram had been done 5 years before the accident because of a family history of cardiomyopathy, and was normal, without evidence of valvular pathology.
A transesophageal echocardiogram showed intact mitral leaflets, without evidence of endocarditis or paravalvular abscess (Movie I in the online-only Data Supplement). However, there was marked disruption and fistulization of the anterior mitral annulus with a 9 × 7 mm irregularly shaped opening at the base of the A2/A3 mitral valve scallops ( Figure A 
. Biventricular cavity size, systolic function, and estimated pulmonary artery systolic pressure were within normal limits.
In summary, these findings demonstrated a left ventricular to left atrial fistula through the anterior mitral annulus, acquired as a result of rapid deceleration injury from a fall. Because the patient was free of cardiovascular symptoms, and the probability of the need for valve replacement during repair was high, the recommendation was made to delay primary repair of the defect until the onset of symptoms or standard echocardiographic signs of left ventricular decompensation. Frequent clinical and echocardiographic follow-up was scheduled.
Disruption of the mitral annulus is well described as a consequence of (1) infective mitral endocarditis with paravalvular abscess formation 1 and (2) cardiac surgery, usually, mitral or aortic valve replacement.
2 Cardiac trauma as a result of a fall from heights is likewise well described and is frequently fatal, because it typically involves rupture of the atrial or ventricular free wall with rapid exsanguination. In other types of cardiovascular deceleration injury, such as that resulting from motor vehicle accidents, disruption of the most anterior cardiac structures is most frequently seen: avulsion of the tricuspid valve, aortic disruption, and right ventricular contusion. 3, 4 In case of aortic disruption, the ligamentum arteriosum is thought to serve as a rigid anchor, while the surrounding tissues continue in motion on impact, thus shearing the aorta. Likewise, in our patient, the fibrous skeleton of the heart at the confluence of the aortic and mitral valves presumably served as an anchor, while the valve apparatus itself continued motion. This discrepancy resulted in shear injury and fistulization of the anterior mitral annulus. To our knowledge, we describe the first case of survivable traumatic disruption of the mitral annulus.
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Methods

Procurement of tissues for analyses
We examined stenotic aortic valves (CAVD) that were explanted from patients at the time of aortic valve replacement. Control non-calcified aortic valves with normal echocardiographic analyses were obtained during heart transplant procedures. Patients with a history of rheumatic disease, endocarditis, and inflammatory diseases were excluded. Valves with moderate to severe aortic valve regurgitation (grade˃2) were excluded. The protocol was approved by the local ethical committee and informed consent was obtained from the subjects.
Remodelling score
The remodeling scores were determined by cardiovascular pathologists (C.C., S.T., S.P.)
as previously described.
1
VICs isolation
Human VICs were isolated from control non-mineralized aortic valves obtained from patients undergoing heart transplantation. Aortic leaflets were incubated in 1mg/ml type I collagenase at 37°C for 30 minutes, then washed in HEPES1X, cut into pieces and incubated in 4.5mg/ml type I collagenase at 37°C for 30 minutes. Tissues were then washed in normal medium 3 times and seeded. Cells were used between passages 3 to 7.
ATX activity
Control non-mineralized and CAVD valve tissues were homogenized and harvested in Tris-buffered saline (140 mM NaCl, 5 mM KCl, 1 mM CaCl 2 , 1 mM MgCl 2 , 50 mM Tris, pH 8.0). Samples were incubated for 15 minutes at 37°C. The reaction was initiated with the addition of FS-3 (Echelon Biosciences, UT, USA) at a final concentration of 3 μM. The reaction was allowed to proceed at 37°C for 1h and the fluorescence was monitored at 520 nm. ATX activity was also measured in human plasma and Lp(a) fraction according to the same protocol. Lp(a) was either purified from human plasma or purchased from (Biomedical Technologies, MA, USA). 2 Results were normalized to protein contents.
Western blotting
Tissue pieces were mixed with lysis buffer (150mM NaCl, 20mM Tris pH7.5, 10%
glycerol, 5mM EGTA, 5mM EDTA, 2mM sodium vanadate, 50mM sodium fluoride, 1%
triton X-100, 0.1% SDS, 80mM β-glycerophosphate, 5mM sodium pyrophosphate, 1mM
PMSF and protease inhibitor cocktail). Mechanical lysis was performed by using a polytron, following centrifugation, supernatants were harvested and protein loading buffer was added. Extracts were boiled 5 minutes, proteins were loaded onto polyacrylamide gels followed by electrophoresis and transferred onto nitrocellulose membranes. Membranes were blocked with TBS-tween containing 5% non-fat dry milk, incubated with ATX (Fisher ThermoScience, QC, Canada) and β-actin (Sigma-Aldrich, ON, Canada) antibodies overnight at 4°C. Membranes were then washed and incubated with HRP-labeled secondary antibodies (Cell Signaling Technology, MA, USA).
Detection was done using clarity western ECL substrate (BioRad, ON, Canada). Images were acquired and quantification analyses were performed using a ChemiDocMP system (BioRad, ON, Canada).
Quantification of lysophosphatidylcholine and lysophosphatidic acid by thin layer chromatography
Aortic cusps were homogenized for 30 seconds in 3mL CHCl 3 :CH 3 OH (2:1) containing 1% butylated hydroxytoluene. Solids were allowed to settle, then supernatants were decanted and pellets were stored at 4°C. The extraction procedure was repeated twice and samples were evaporated to dryness. Dry extracts were dissolved in 1mL CHCl 3 :CH 3 OH (10:1) and 20µl was applied to a thin-layer chromatography plate (20cm×20 cm).
Samples were first migrated in CHCl 3 :CH 3 OH:H 2 O (65:24:4) and then in hexane: diethyl ether:acetic acid (75:35:1). Visualization was performed using 0.1% Amido Black 10b in 1M NaCl.
Immunostaining analyses
Immunostaining or 3 were given respectively when less than 25%, 25-50%, and more than 50% of the valve area was specifically immunostained.
Immunofluorescence of human aortic leaflets
Tissues were fixed in a solution of acetone-methanol (60:40), quenched in 50mM NH 4 
Proximity ligation assay
Six μm slices were cut from OCT embedded human mineralized aortic valve leaflets.
Tissues were fixed with acetone:methanol (60:40) 10 minutes at -20°C, followed by quenching in 50mM NH 4 Cl for 30 minutes at room temperature. Permeabilization was then performed in 0.2% triton (in PBS1X) for 10 minutes with constant agitation.
Following permeabilization, the proximity ligation assay (Olink Bioscience, Sweden) was performed according to the manufacturer's instructions using monoclonal antibody 4H1 (Fisher ThermoScience, QC, Canada) that recognizes apolipoprotein (a) (fragment 4330-4521) and polyclonal antibody against ATX (Fisher ThermoScience, QC, Canada).
Samples were analysed using a confocal microscope system (FV1000, Olympus, ON, Canada, objective 60X oil, NA1.42) driven by Fluoview software (FV-10 ASW 3.1, Olympus). Merges were performed with ImageJ 1.47g (NIH, USA).
Immunofluorescence of cells
Human 
P65 translocation
Cells were treated with lysophosphatidylcholine for 30 minutes at 37°C, fixed in 3.7%
formaldehyde for 30minutes at 37 °C and treated 15 minutes with a 50 mM NH 4 Fisher Scientific,ON, Canada) was used as a reference gene to normalize the results.
In vitro analyses of calcification
Cells were incubated for 7 days with a pro-calcifying medium containing: DMEM + 5% FBS, 10 -7 M insulin, 50 μg /ml ascorbic acid and NaH 2 PO 4 at 2 mM. The medium was supplemented with lysophosphatidylcholine (100 nM) (Sigma-Aldrich, ON, Canada), 
Quantification of IKKα and pIKKα
VICs were collected in cell lysis buffer. CAVD tissues were homogenized in lysis buffer.
Lysates were used directly in ELISA kit (PathScan®IIKα/Phospho-IKKα (Ser176/180), Cell Signaling Technology, Inc., USA). The quantification of IKKα and phospho-IKKα was determined in accordance with the manufacturer's instructions and normalized with protein content.
Measurement of IL-6 in supernatants IL-6 was measured in supernatants of human VICs exposed to lysophosphatidylcholine, Ki6425 or lysophosphatidic acid for 48 hours. IL-6 was measured by ELISA (R&D Systems, MN, USA) according to manufacturer's instructions.
Measurement of ATX in supernatants
ATX was measured in supernatants of human VICs using ELISA (Echelon Biosciences, UT, USA) according to manufacturer's instructions and normalized with protein content.
Animals
All animal protocols were conducted according to guidelines set out by the Laval University Animal Care and Handling Committee and are conform with the NIH guidelines for the care and use of laboratory animals. LDLR -/-/ApoB 100/100 /IGF2 (on C57Bl/6J background) were generated from an established colony at the Quebec Heart and Lung Institute of Laval University from original founders kindly provided by Dr.
SeppoYlä-Herttuala (University of Eastern Finland, Finland). C57BL/6 mice were purchased from Jackson Laboratories (MA, USA). Male mice were housed in a pathogenfree, temperature-controlled environment under a 12:12 hour light-dark cycle and fed ad libitum of a high fat, high sucrose, cholesterol diet (55% calories from fat, 28% from sucrose, 0.2% cholesterol) for 6 months starting at 12 weeks of age. At the end of protocol, mice were sacrificed by anesthesia under isoflurane (2-3%, inhalation) and cardiac puncture, which was performed by a qualified animal care technician.
Echocardiography in mice
The investigator performing echocardiography analyses was blinded to the group allocation. Transthoracic echocardiography was performed under 2.5%-isofluorane anaesthesia, with a L15-7io (5-12 Megaherz) and S12-4 (4-12 Megaherz) probes connected to a Philips HD11XE ultrasound system (Philips Healthcare Ultrasound, Pulsed-wave Doppler was used to record transmitral flow in the apical 4-chamber view
and from this signal we measured peak velocity of E-and A-waves. Mitral annulus motion velocity was recorded by tissue Doppler imaging, velocity during early filling E'
was measured, and E/E' ratio was calculated. Continuous-wave Doppler was also used to record aortic jet flow velocity in the apical 5-chamber view and peak aortic jet velocity and velocity-time integral were measured. The average of 3 consecutive cardiac cycles was used for each measurement. Special care was taken to get similar imaging planes at follow-up studies.
Alizarin red staining of mouse tissues
Hearts were perfused with HEPES, and embedded in OCT. Hearts were cut exposing leaflets and 6 µm slices were made. Sections were fixed with acetone-methanol (60:40), 
Cholesterol and triglycerides measurements in mice
Plasma cholesterol and triglycerides assay was done according to the protocol Company (Randox, Crumlin, United Kingdom). 
Statistical analyses
